Neuroimaging in Parkinson's Disease and Related Disorders

University of Exeter, United KingdomMarios Politis is a Professor of Neurology, Consultant Neurologist, the Director of Mireille Gillings Neuroimaging Center, and the Director of the Neurodegeneration Imaging Group at University of Exeter. His research involves clinical observation and the use of PET and MR imaging as a method of investigating etiology, pathophysiology, and effects and complications of novel therapies in neurodegenerative disorders such as Parkinson’s disease. He has served as a chief investigator in a number of observational and interventional trials. Professor Politis has received a high number of awards and distinctions such as from the Movement Disorder Society, Royal College of Physicians, Society of Nuclear Medicine and Molecular Imaging, and European Academy of Neurology. He is a recipient of the John Stolk Award in Movement Disorders from the American Academy of Neurology. Heather Wilson, MSc. PhD, is a Senior Research Fellow at the Neurodegeneration Imaging Group, and Imaging Methodology Lead at the Mireille Gillings Neuroimaging Centre, University of Exeter. Edoardo Rosario de Natale is a Senior Clinical Research Fellow at the Neurodegeneration Imaging Group at University of Exeter, lead of the clinical applications at the Mireille Gillings Neuroimaging Centre and honorary Consultant at the Royal Devon & Exeter NHS Foundation Trust.

• Section I. Introduction1. Parkinson’s disease and related disorders: The pursuit for reliable readouts and the role of neuroimaging2. Advances in magnetic resonance imaging3. Advances in molecular neuromaging methodologySection II. Clinical Applications in Parkinson's Disease4. Dopaminergic molecular imaging in familial and idiopathic Parkinson's disease5. Serotonergic molecular imaging in familial and idiopathic PD6. Molecular imaging beyond dopamine and serotonin in familial and idiopathic Parkinson's disease7. Structural MRI in familial and idiopathic PD8. Functional MRI in familial and idiopathic PD9. Molecular imaging in prodromal Parkinson's diseaseSection III. Clinical Applications in Lewy Body Dementias10. Molecular imaging evidence in favor or against PDD and DLB overlap11. Magnetic resonance imaging in Parkinson's disease with mild cognitive impairment, Parkinson's disease dementia, and dementia with Lewy bodiesSection IV. Clinical Applications in Atypical Parkinsonian Disorders12. Neuroimaging in multiple system atrophy13. Neuroimaging in progressive supranuclear palsy14. Neuroimaging in corticobasal syndromeSection V. Clinical Applications in Other Movement Disorders15. Molecular imaging in Huntington's disease16. Magnetic resonance imaging in Huntington’s disease17. Neuroimaging in essential tremor 18. Neuroimaging in restless legs syndrome 19. Neuroimaging in dystonia20. Demyelinating syndromes and movement disorders